Aethlon Medical Partners with Maxim Group to Explore New Strategies Aethlon Medical has enlisted Maxim Group as its financial advisor to assess strategic opportunities. The company is focusing on potential partnerships and acquisitions.

Aethlon Medical Partners with Maxim Group to Explore New Strategies #United_States #San_Diego #Cancer_Treatment #Aethlon_Medical #Maxim_Group

Aethlon Medical Successfully Closes Private Placement with Gross Proceeds of $3.3 Million Aethlon Medical, Inc. announces a private placement to raise $3.3 million aimed at advancing its cancer treatment technologies, following a recent financing agreement.

Aethlon Medical Successfully Closes Private Placement with Gross Proceeds of $3.3 Million #USA #San_Diego #Cancer_Treatment #Aethlon_Medical #Hemopurifier

Aethlon Medical Reports Promise in Treating Long COVID with Hemopurifier® Device Aethlon Medical unveils promising preclinical data supporting its Hemopurifier® device's ability to target inflammation in Long COVID patients.

Aethlon Medical Reports Promise in Treating Long COVID with Hemopurifier® Device #USA #San_Diego #Aethlon_Medical #Hemopurifier #GNA_Affinity_Resin

Aethlon Medical Reports Q2 Financial Outcomes and Progress on Cancer Treatment Innovations Aethlon Medical shares its financial results for Q2 FY2025, highlighting clinical advancements in cancer treatment and cost reduction strategies.

Aethlon Medical Reports Q2 Financial Outcomes and Progress on Cancer Treatment Innovations #United_States #San_Diego #Clinical_Trials #Aethlon_Medical #Hemopurifier

Aethlon Medical’s Hemopurifier Shows Promise in Australian Oncology Trials Aethlon Medical, Inc. reports early encouraging results from its Hemopurifier oncology trial in Australia, showcasing potential shifts in patient biomarkers.

Aethlon Medical’s Hemopurifier Shows Promise in Australian Oncology Trials #Australia #Sydney #Aethlon_Medical #Hemopurifier #Oncology_Trials

Aethlon Medical Unveils Plans for $4.5 Million Public Offering for Cancer Therapeutics Aethlon Medical, Inc. has priced a public offering aimed at raising $4.5 million for developing cancer treatments and addressing infectious diseases.

Aethlon Medical Unveils Plans for $4.5 Million Public Offering for Cancer Therapeutics #USA #San_Diego #Cancer_Treatment #Aethlon_Medical #Hemopurifier

Aethlon Medical Releases First Quarter Financial Results and Corporate Updates for 2025 Aethlon Medical, Inc. shares insights on fiscal Q1 results for 2025, highlighting clinical trial progress, operating efficiency, and future directions.

Aethlon Medical Releases First Quarter Financial Results and Corporate Updates for 2025 #United_States #San_Diego #Aethlon_Medical #Hemopurifier #cancer_trial

Aethlon Medical's Hemopurifier Advances to Next Clinical Trial Phase Following Positive Safety Review Aethlon Medical's Hemopurifier progresses to the next clinical trial phase as the Data Safety Monitoring Board gives a positive safety review after initial findings.

Aethlon Medical's Hemopurifier Advances to Next Clinical Trial Phase Following Positive Safety Review #USA #San_Diego #Clinical_Trials #Aethlon_Medical #Hemopurifier

Aethlon Medical’s Fourth Quarter Financial Results and Corporate Updates Reflecting Progress in Cancer Treatment Trials Aethlon Medical has announced its fiscal fourth quarter financial results, showing significant progress in cancer trials and operational efficiencies. Key achievements include regulatory approvals and clinical treatment milestones.

Aethlon Medical’s Fourth Quarter Financial Results and Corporate Updates Reflecting Progress in Cancer Treatment Trials #USA #San_Diego #Cancer_Treatment #Aethlon_Medical #Hemopurifier

Aethlon Medical Marks Progress with Australian Hemopurifier® Cancer Trial Treatment for Patients Aethlon Medical has treated its second patient in Australia using the Hemopurifier device, a promising step in cancer therapy for resistant tumors.

Aethlon Medical Marks Progress with Australian Hemopurifier® Cancer Trial Treatment for Patients #Australia #Sydney #Aethlon_Medical #Hemopurifier #cancer_trial

Aethlon Medical Presents Groundbreaking Research on Long COVID at Keystone Symposium Aethlon Medical highlights significant pre-clinical findings on Long COVID at the Keystone Symposium, addressing the urgent need for effective treatments.

Aethlon Medical Presents Groundbreaking Research on Long COVID at Keystone Symposium #United_States #Aethlon_Medical #Hemopurifier #Long_COVID #Santa_Fe,_NM

Aethlon Medical's Hemopurifier® Shows Promise in Cancer Treatment by Removing Harmful Vesicles Aethlon Medical reveals groundbreaking preclinical data on Hemopurifier’s ability to eliminate harmful platelet-derived vesicles, enhancing cancer treatment.

Aethlon Medical's Hemopurifier® Shows Promise in Cancer Treatment by Removing Harmful Vesicles #USA #San_Diego #Aethlon_Medical #Hemopurifier #Platelet-derived_EVs

Aethlon Medical's Hemopurifier® Shows Promise in Transplant Research Aethlon Medical has shared exciting preclinical research on its Hemopurifier®, highlighting its potential in organ transplant applications.

Aethlon Medical's Hemopurifier® Shows Promise in Transplant Research #United_States #San_Diego #Aethlon_Medical #Hemopurifier #transplant_research

Aethlon Medical Set to Showcase Breakthrough Cancer Treatments at 2025 Emerging Growth Conference Aethlon Medical will present innovative therapies targeting cancer and infectious diseases at the Emerging Growth Conference. CEO James Frakes will interact with investors in real time.

Aethlon Medical Set to Showcase Breakthrough Cancer Treatments at 2025 Emerging Growth Conference #USA #San_Diego #Aethlon_Medical #Hemopurifier #James_Frakes

Aethlon Medical Reports Third Quarter Financial Results and Future Plans for Hemopurifier Trial Aethlon Medical shares financial results for Q3, highlighting progress in its Hemopurifier clinical trials in Australia and India, and announces cost-reduction strategies.

Aethlon Medical Reports Third Quarter Financial Results and Future Plans for Hemopurifier Trial #United_States #San_Diego #Aethlon_Medical #Hemopurifier #cancer_trial

Aethlon Medical's Hemopurifier Trial Marks First Patient Treatment in Australia Aethlon Medical successfully treats its first patient in Australia with Hemopurifier, targeting cancer resistant to anti-PD-1 therapies.

Aethlon Medical's Hemopurifier Trial Marks First Patient Treatment in Australia #Australia #Adelaide #Aethlon_Medical #Hemopurifier #cancer_trial

Aethlon Medical Unveils Promising Hemopurifier Device for Combatting H5N1 Bird Flu Aethlon Medical provides crucial updates on its Hemopurifier device's potential to treat H5N1 Bird Flu amidst growing health concerns.

Aethlon Medical Unveils Promising Hemopurifier Device for Combatting H5N1 Bird Flu #Aethlon_Medical #Hemopurifier #H5N1_Flu